Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Brief description not available

Researchers at UCSF and the Chan Zuckerberg Biohub have developed methods to detect SARS-CoV-2 virus.

Researchers at UCSF and the Chan Zuckerberg Biohub have developed a serological detection assay for anti-SARS-CoV-2 antibodies. 

Researchers at UCSF and the Chan Zuckerberg Biohub have developed a set of ACE2 variants which potently block SAR-CoV-2 infection in cells. 

UCSF PIs developed a novel software platform for COVID-19 contact tracing and hotspotting called COVIDseeker. Covidseeker looks back in time and may be able to recreate people’s movements when infection rates were rising and falling in the spring and summer of 2020, giving epidemiologists an invaluable source of data as they try to predict what is going to happen in the fall and winter.This digital health invention has applications broader than COVID-19. The software can potentially be leveraged for other infectious diseases, treating obesity, and controlling smoking or alcohol addiction by showing where and when people are when they smoke, what are the triggers and how their location contributes to the risk of developing a particular disease.

This diagnostic technology uses a panel of 20 biomarkers to diagnose Lyme disease with much higher sensitivity and accuracy than other currently existing methods. Lyme disease can be detected in peripheral blood samples from patients even at early hard-to-diagnose stages. These aspects of the invention make it indispensable for speeding up recovery and prevention of complications associated with this debilitating illness such as carditis, arthritis, neurological illness and even death.

This invention identifies a novel class of HIV inhibitors targeting RNA-protein interactions.

This invention identifies a novel class of natural protein-based inhibitors of CRISPR-Cas9, which could eliminate off-target effects of Cas9-mediated gene editing. It also presents an attractive antibiotic strategy and a potential biodefense agent against CRISPR bioterror threat.

UCSF researchers have invented a novel method to generate covalent macromolecular inhibitors. This strategy allows a peptide inhibitor to bind to its target protein specifically and irreversibly through proximity-enabled bioreactivity.

UCSF researchers have invented novel radiotracers that allow imaging of both gram-positive and gram-negative bacteria infections using positron emission tomography (PET) to detect spread of infection and to distinguish that from other mimics.

UCSF researchers have generated and validated a K14-HPV16 transgenic mouse model, in which transgene expression produces neoplastic progression that fully resembles the gynecological and other epithelial dysplastic lesions induced by high risk HPVs. This model offers an invaluable tool for studying HPV infection and developing new drugs for HPV treatment.